Article Information
History
- January 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Sudeb C. Dalai1,2,*,
- Jennifer N. Dines1,
- Thomas M. Snyder1,
- Rachel M. Gittelman1,
- Tera Eerkes1,
- Pashmi Vaney1,
- Sally Howard1,
- Kipp Akers1,
- Lynell Skewis1,
- Anthony Monteforte1,
- Pam Witte1,
- Cristina Wolf1,
- Hans Nesse1,
- Megan Herndon1,
- Jia Qadeer1,
- Sarah Duffy1,
- Emily Svejnoha1,
- Caroline Taromino1,
- Ian M. Kaplan1,
- John Alsobrook1,
- Thomas Manley1 and
- Lance Baldo1
- 1Adaptive Biotechnologies, Seattle, Washington, USA
- 2Stanford University School of Medicine, Stanford, California, USA
- ↵*Corresponding author: Sudeb C. Dalai, MD, PhD, Senior Medical Director, Adaptive Biotechnologies, Seattle, WA, USA, sdalai{at}adaptivebiotech.com, (617) 335-2355
Posted January 08, 2021.
Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection
